KO-Validated ATF6 Recombinant Rabbit Monoclonal Antibody

KO-Validated ATF6 Recombinant Rabbit Monoclonal Antibody

Cat. No.: KVAb00064
Size:20μL Price:$118
Size:50μL Price:$218
Size:100μL Price:$318
Application:WB,FCM,ICC

Reactivity:Human
Conjugate:Unconjugated
Gene Name:ATF6
Category: KO&KD Validated Antibodies Tags: , , , , , ,

Summary

Production Name

KO-Validated ATF6 Recombinant Rabbit Monoclonal Antibody

Description

KD-Validated antibody

Host

Rabbit

Application

WB,FCM,ICC

Reactivity

Human

 

Performance

Conjugation

Unconjugated

Modification

Unmodified

Isotype

Rabbit IgG

Clonality

Rabbit mAb

Form

Liquid

Storage

Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles.

Buffer

Supplied in PBS (pH 7.4) containing 50% glycerol, and 0.02% sodium azide.

Purification

Affinity purification

 

Immunogen

Gene Name

ATF6

Alternative Names

ATF6; Activating Transcription Factor 6; ATF6A; Cyclic AMP-Dependent Transcription Factor ATF-6 Alpha; CAMP-Dependent Transcription Factor ATF-6 Alpha; Activating Transcription Factor 6 Alpha; ATP6alpha; ATF6-Alpha; ACHM7

Gene ID

22926

SwissProt ID

P18850

 

Application

Dilution Ratio

WB 1:1,000-1:5,000; FC 1:200-1:2,000; ICC 1:100-1:1,000

Molecular Weight

Calculated MW: 74.6kDa

 

Background

This gene encodes a transcription factor that activates target genes for the unfolded protein response (UPR) during endoplasmic reticulum (ER) stress. Although it is a transcription factor, this protein is unusual in that it is synthesized as a transmembrane protein that is embedded in the ER. It functions as an ER stress sensor/transducer, and following ER stress-induced proteolysis, it functions as a nuclear transcription factor via a cis-acting ER stress response element (ERSE) that is present in the promoters of genes encoding ER chaperones. This protein has been identified as a survival factor for quiescent but not proliferative squamous carcinoma cells. There have been conflicting reports about the association of polymorphisms in this gene with diabetes in different populations, but another polymorphism has been associated with increased plasma cholesterol levels. This gene is also thought to be a potential therapeutic target for cystic fibrosis. [provided by RefSeq, Aug 2011]

 

Research Area

Epigenetics and Nuclear Signaling

   💬 WhatsApp